MEREO BIOPHARMA GROUP PLC Other Comprehensive Income Net Of Tax Exchange Differences On Translation
MEREO BIOPHARMA GROUP PLC (MREO) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -GBP 499.00 thousand for the 12-month period ending 2020-12-31, per its 20-F filed 2021-03-31.
Discontinued › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2021-03-31
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|
| 2020-12-31 | -499.00K GBP 20-F · filed 2021-03-31 |
| 2019-12-31 | -499.00K GBP 20-F · filed 2020-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |